StockNews.com Initiates Coverage on Senseonics (NYSE:SENS)

Investment analysts at StockNews.com began coverage on shares of Senseonics (NYSE:SENS) in a note issued to investors on Thursday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and set a $2.00 target price on shares of Senseonics in a report on Friday, November 15th.

Senseonics Stock Up 1.1 %

Senseonics stock opened at $0.59 on Thursday. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The company’s 50-day moving average is $0.35 and its 200-day moving average is $0.38. The firm has a market capitalization of $352.55 million, a PE ratio of -4.56 and a beta of 0.77. Senseonics has a fifty-two week low of $0.25 and a fifty-two week high of $0.75.

Insider Transactions at Senseonics

In other Senseonics news, CFO Frederick T. Sullivan acquired 124,933 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was acquired at an average price of $0.38 per share, for a total transaction of $47,474.54. Following the purchase, the chief financial officer now directly owns 2,478,844 shares of the company’s stock, valued at $941,960.72. This trade represents a 5.31 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Timothy T. Goodnow acquired 315,000 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was acquired at an average cost of $0.31 per share, with a total value of $97,650.00. Following the acquisition, the chief executive officer now directly owns 11,310,355 shares in the company, valued at approximately $3,506,210.05. This trade represents a 2.86 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.60% of the company’s stock.

Hedge Funds Weigh In On Senseonics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its position in Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after purchasing an additional 179,103 shares during the period. FMR LLC increased its stake in Senseonics by 48,267.2% in the third quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after acquiring an additional 167,970 shares during the last quarter. GSA Capital Partners LLP bought a new stake in Senseonics during the third quarter worth $117,000. Symmetry Partners LLC acquired a new stake in shares of Senseonics in the 3rd quarter valued at $164,000. Finally, Cubist Systematic Strategies LLC increased its stake in shares of Senseonics by 25.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after purchasing an additional 85,501 shares during the last quarter. 12.36% of the stock is owned by institutional investors and hedge funds.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.